Periodic Reporting for period 1 - Unusual-IV (Intraveneously injected unusual nanoparticles in the clinic)

Imaging agents are a difficult market to penetrate, in part due to the difficult and unclear regulatory requirements. In this project, we are building on previous developments by Cenya Imaging BV on the use to imaging agents for in vivo cell tracking, to explore and develop...